Bitdeer Technologies
BTDR
BTCS Inc
BTCS
Bit Digital
BTBT
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
BIT Mining
BTCM
US Stock MarketDetailed Quotes
REPL Replimune
- 13.190
- +0.050+0.38%
Trading Dec 4 15:52 ET
993.74MMarket Cap-4338P/E (TTM)
13.680High13.075Low505.23KVolume13.400Open13.140Pre Close6.68MTurnover1.00%Turnover RatioLossP/E (Static)75.34MShares17.00052wk High2.66P/B666.49MFloat Cap4.92052wk Low--Dividend TTM50.53MShs Float54.850Historical High--Div YieldTTM4.60%Amplitude4.920Historical Low13.217Avg Price1Lot Size
About Replimune Company
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Company Profile
SymbolREPL
Company NameReplimune
Listing DateJul 20, 2018
Issue Price15.00
Founded2017
CEODr. Sushil Patel, PhD
MarketNASDAQ
Employees331
Fiscal Year Ends03-31
Address500 Unicorn Park Drive,Suite 303,3rd Floor
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-222-9600
Websitehttp://www.replimune.com
Company Executives
- Name
- Position
- Salary
- Dr. Sushil Patel, PhD
- Director and Chief Executive Officer
- --
- Paul Bullock
- Chief Manufacturing Officer
- --
- Christopher Sarchi
- Chief Commercial Officer
- --
- Emily Hill
- Chief Financial Officer
- 3.38M
- Andrew Schwendenman
- Chief Accounting Officer
- --
- Dr. Konstantinos Xynos, M.D.
- Chief Medical Officer
- 2.45M
- Philip Astley-Sparke
- Executive Chairman of the Board
- 6.02M
- Madhavan Balachandran
- Independent Director
- --
- Paolo Pucci
- Independent Director
- 360.10K
- Christy J. Oliger
- Independent Director
- 352.60K
- Joseph P. Slattery, C.P.A.
- Independent Director
- 362.60K
- Veleka Peeples-Dyer
- Independent Director
- 667.97K
- Dieter Weinand
- Lead Independent Director
- 516.81K
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 357.60K